Executive Lookbook

• M.D., McGill University

• Director, Osher Center for Integrative Medicine
• Professor-in-residence of medicine at Harvard Medical School

• Served as director of the Osher Center for Integrative Medicine, jointly based at Brigham and Women's Hospital and Harvard Medical School, and professor-in-residence of medicine at Harvard Medical School.
• Served as a visiting professor of neurological sciences at the University of Vermont Larner College of Medicine, Burlington.
• Her research interests have centered around the role of connective tissue in low back pain and the mechanisms of acupuncture, manual, and movement-based therapies. Her recent work focuses on the effects of stretching on inflammation resolution mechanisms within connective tissue.
• Completed her postdoctoral research fellowship in neurochemistry at the Medical Research Council Neurochemical Pharmacology Unit in Cambridge, England, and a residency in internal medicine and fellowship in endocrinology and metabolism at The Johns Hopkins Hospital in Baltimore.

• Ph.D., The American University

• B.S., University of Massachusetts, Amherst

• Former Extramural Director of the Division of Basic Neuroscience and Behavioral Research.
• Recipient of several NIH Director's Awards.

• Ph.D., The American University

• B.S., University of Massachusetts, Amherst

• Former Extramural Director of the Division of Basic Neuroscience and Behavioral Research.
• Recipient of several NIH Director's Awards.

M.D., University of Zagreb 

• Clinical Professor, University of Washington
• Professor of Neurology, University of Wisconsin
• Pain Franchise Executive Director, Contract Research Organizations
• Supervisory Clinical Physician, NCCIH

• Development of neuropathology pain questionnaire. 
• Established the role of Quantitative Sensory Testing for pain disorders.
• Developed innovative models of early phase pain clinical trials.

• B.S., Frostburg State University

• Deputy Executive Officer, NCCIH
• Senior Administrative Officer, NIDCR

• Recipient of NIH Director's Award and the OD Honor Award.
• Graduate of NIH Senior Leadership Program.

• M.D. Stanford University 
• Ph.D., Stanford University 
• M.M.H.C., Vanderbilt University 
• B.SA., University of Northern Iowa 

• Chair, Department of Medicine, Physician-in-Chief – Vanderbilt University Medical Center
• Deputy Director, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
• Director, Division of Hematology and Oncology – Vanderbilt University Medical Center
• Associate Professor, Associate Direct - University of North Carolina at Chapel Hill

• Elected to the National Academy of Medicine – for pioneering work in kidney cancer and creating pathways to support physician-scientist career development.
• First woman to receive the Eugene P. Schonfeld Award from the Kidney Cancer Association 
• Recipient of the Paragon Award for Research Excellence from the Doris Duke Foundation 
• Elected to the American Academy of Arts and Science – for contributions to cancer biology and career development
• Winner of the 2020 American Association for Cancer Research Team Science Award for contributions to The Cancer Genome Atlas

• M.D., NYU School of Medicine
• B.A., Amherst College

• Co-Developer of the Human Papilloma Virus (HPV) vaccine.
• 2007 Federal Employee of the Year.
• 2011 Sabin Gold Medal
• 2014 National Medal of Technology and Innovation.
• 2017 Lasker~DeBakey Clinical Medical Research Award

M.D., Harvard Medical School

• Known for elucidating the contribution of oxidant stress to the mechanism of action and cardiac toxicity of the anthracycline antibiotics and other classes of anticancer
• Discovered glutathione peroxidase 2 which plays an essential role in protecting gastrointestinal crypt cells from peroxidative injury
• Developed the role of “Phase 0” pharmacodynamic clinical trials in cancer drug discovery
• Led the National Cancer Institute’s ten year effort to comprehensively restructure its clinical trials enterprise

Ph.D., Columbia University

• Director, Division of Cancer Biology, NCI
• Senior Investigator, Experimental Immunology Branch, Center for Cancer Research, NCI

• Known for characterization of the molecular mechanisms regulating transcription of Major Histocompatibility Class I genes
• Discovered mechanisms coordinating chromatin structure and transcription, and mechanisms linking transcription and translation
• Developed research networks to advance studies in mouse models of human cancer, cancer systems biology, tumor microenvironment
• Led NCI’s Cancer Moonshot effort 

• M.D., Harvard Medical School
• A.B., Princeton University

• Chief, Pediatric Oncology Branch, NCI
• Acting Chief, Medical Oncology Branch, NCI

• Author of over 800 scientific papers
• Leading expert on the discovery and characterization of cancer susceptibility regions in the human genome
• Medical Director for Camp Fantastic , a week-long recreational camp for pediatric cancer patients, which is a joint venture of the NCI and Special Love, Inc.

M.D., University of Vermont College of Medicine

B.S., Worcester Polytechnic Institute 

• Research Scholar, Howard Hughes Medical Institute/National Institutes of Health Research Scholars Program, Laboratory of Pathology, National Cancer Institute, National Institutes of Health
• Attending Physician,  Pediatric Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health
• Investigator, Tenure-Track: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

• NIH Merit Award, Individual, for developing DCEG’s Genetic Epidemiology of Telomere Maintenance in Cancer Etiology research program, and discovering the TINF2 dyskeratosis congenita susceptibility gene
• Elected to Society for Pediatric Research
• Elected to American Society for Clinical Investigation
• NCI Outstanding Mentor Award, National Cancer Institute, NIH
• NCI Director’s Award of Merit for COVID-19 Pandemic Infrastructure and Administration Leadership
• Robert H. Goddard Alumni Award for Outstanding Professional Achievement, Worcester Polytechnic Institute

• Ph.D., University of Michigan, Ann Arbor, Michigan
• B.A., Adelphi University, Long Island, New York (Summa Cum Laude)

• Deputy Director, Center for Cancer Research
• Inaugural Member, CCR Science Board
• Adjunct Professor, University of Maryland Regional College of Veterinary Medicine

• M.D., Ph.D., Loma Linda University

• Deputy Chief, Laboratory of Tumor Immunology and Biology
• CCR, NCI Chief, Genitourinary Malignancies Branch,
• CCR, NCI Director, Medical Oncology Service, CCR, NCI  

• Known for expertise in immunotherapy, having designed and conducted >100 clinical trials from first-in-human / first-in-class therapies to randomized controlled registration endpoint studies.
• 2010 Presidential Early Career Award for Scientists and Engineers, the highest award bestowed by the US President on investigators early in their careers.
• 2018 Hubert H. Humphrey Award for Service to America for contributing to the health, safety, and well-being of the nation by helping to get FDA approval for avelumab for Merkel cell carcinoma and urothelial carcinoma.
• Multiple other awards including 10 NCI or NIH Director’s Awards. 

• Ph.D., University of Michigan, Ann Arbor, Michigan
• B.A., Adelphi University, Long Island, New York (Summa Cum Laude)

• Deputy Director, Center for Cancer Research
• Inaugural Member, CCR Science Board
• Adjunct Professor, University of Maryland Regional College of Veterinary Medicine

The Cancer Modeling Section seeks to elucidate the complex molecular/genetic program governing tumor genesis and progression through the development of genetically engineered mouse models of human cancer. A major goal is to identify candidate targets or pathways for both mechanistic enlightenment and future therapeutic utility. Our efforts in this regard are focused predominantly on cutaneous malignant melanoma.

Ph.D., University of London, UK

• Pioneered the field of cell biology of genomes
• Co-author of the “Precision Medicine” report by the US National Academies of Sciences
• Recipient of the Gian-Tondury Prize, Gold Medal of The Charles University Prague, Flemming Award, Wilhelm Bernhard Medal, Robert Felugen Prize, Herman Beerman Award